|
|
Volumn 190, Issue 3, 2009, Pages 243-247
|
|
EMS in Viracept-The course of events in 2007 and 2008 from the non-clinical safety point of view
a
|
|
Author keywords
Ethyl methanesulfonate; Nelfinavir mesilate; Patient exposure risk; Regulatory interaction; Viracept
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTIRETROVIRUS AGENT;
MESYLIC ACID ETHYL ESTER;
NELFINAVIR;
RITONAVIR;
ARTICLE;
CARCINOGEN DNA INTERACTION;
CHROMOSOME DAMAGE;
CONCENTRATION (PARAMETERS);
DNA DAMAGE;
DNA REPAIR;
DRUG APPROVAL;
DRUG CHOICE;
DRUG CONTAMINATION;
DRUG LEGISLATION;
DRUG MARKETING;
DRUG QUALITY;
DRUG SAFETY;
DRUG SCREENING;
DRUG STABILITY;
DRUG SURVEILLANCE PROGRAM;
DRUG TOLERABILITY;
GENE MUTATION;
GENOTOXICITY;
HEALTH HAZARD;
HEALTH STATUS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LACTATION;
MOLECULAR MODEL;
MUTAGENESIS;
NAUSEA AND VOMITING;
NONHUMAN;
PATIENT SAFETY;
PREGNANT WOMAN;
PRIORITY JOURNAL;
QUALITY CONTROL;
REFERENCE VALUE;
RISK ASSESSMENT;
TERATOGENICITY;
TOXICOKINETICS;
ADULT;
ANIMALS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG AND NARCOTIC CONTROL;
DRUG CONTAMINATION;
DRUG TOXICITY;
ETHYL METHANESULFONATE;
EUROPEAN UNION;
FEMALE;
HISTORY, 21ST CENTURY;
HIV PROTEASE INHIBITORS;
HUMANS;
MICE;
MUTAGENICITY TESTS;
MUTAGENS;
NELFINAVIR;
NO-OBSERVED-ADVERSE-EFFECT LEVEL;
PREGNANCY;
PRODUCT SURVEILLANCE, POSTMARKETING;
RATS;
REGISTRIES;
RISK ASSESSMENT;
|
|
EID: 70350151197
PISSN: 03784274
EISSN: None
Source Type: Journal
DOI: 10.1016/j.toxlet.2009.02.005 Document Type: Article |
|
Times cited : (36)
|
|
References (9)
|
